Metaplastic breast cancer (MpBC) is an uncommon aggressive malignancy that is
associated with a poor prognosis. Due to its rarity, the relationships between the clinical and …

Metaplastic matrix-producing breast carcinoma is a type of metaplastic breast carcinoma
(MBC), which is a rare malignancy, accounting for 0.2–1% of breast carcinomas. A 52-year …

Abstract Objective Metaplastic breast cancer (MpBC) is an aggressive subtype of all breast
cancer. We aimed to investigate the clinicopathological features, treatments and prognoses …

Rationale and Objectives Metaplastic breast carcinoma (MBC) is an infrequent malignancy
with an unfavorable prognosis, and there is a paucity of research on the multimodal imaging …

Purpose: Models for predicting postoperative overall survival of patients with metaplastic
breast cancer have not yet been discovered. The purpose of this study is to establish a …

Background: Breast squamous cell carcinoma (SCC) is an uncommon and highly
aggressive variant of metaplastic breast cancer. Despite its rarity, there is currently no …

Background Metaplastic breast carcinoma (MBC) is a rare histologic variant of breast cancer
characterized by the presence of glandular and non-glandular components. The prognostic …

Background The rarity of metaplastic breast carcinoma (MBC) has resulted in limited
sonographic data. Given the inferior prognosis of MBC compared to invasive ductal …

Background: There are limited data on the sonographic findings about metaplastic breast
carcinoma (MBC) due to its rarity. This article aimed to determine the value of sonographic …

Background: The breast cancer specific survival (BCSS) benefits of Neoadjuvant therapy
(NeoAT) for triple-negative metaplastic breast cancer (TNMpBC) was uncertain. This study …